Atlas Trials

Apsen Farmaceutica S.A.

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Apsen Farmaceutica S.A.

RecordFirmDate
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia (NCT07516561)Apsen Farmaceutica S.A.2026-07-07
Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder (NCT07420816)Apsen Farmaceutica S.A.2026-03-26
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease (NCT04674735)Apsen Farmaceutica S.A.2023-01-01
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (NCT04637529)Apsen Farmaceutica S.A.2022-08-05
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain (NCT04772781)Apsen Farmaceutica S.A.2022-06-03
Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction (NCT03127592)Apsen Farmaceutica S.A.2020-10-05
Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19) (NCT04361461)Apsen Farmaceutica S.A.2020-04-30
Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions (NCT02956512)Apsen Farmaceutica S.A.2019-03-18
Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions (NCT02956525)Apsen Farmaceutica S.A.2018-04-01

Track Apsen Farmaceutica S.A. automatically

Every clearance here is in the API, with alerts when new ones post.